65 results
Page 2 of 4
424B5
97r6vw2qx7j
11 Sep 20
Prospectus supplement for primary offering
4:44pm
424B5
xi0hj5suh8bx vcsw1
9 Sep 20
Prospectus supplement for primary offering
4:40pm
8-K
EX-99.1
vk5v eqgqlrw
9 Sep 20
Intra-Cellular Therapies Announces Positive Topline Results
7:13am
8-K
6rvl70ggpez8dym
23 Mar 20
Intra-Cellular Therapies Announces Availability of CAPLYTA™ (lumateperone) for Adult Patients with Schizophrenia
7:52am
8-K
EX-99.1
pmd1coh7zupmu z9
23 Mar 20
Intra-Cellular Therapies Announces Availability of CAPLYTA™ (lumateperone) for Adult Patients with Schizophrenia
7:52am
424B5
znjxby dl
8 Jan 20
Prospectus supplement for primary offering
5:06pm
8-K
EX-99.3
ug6n4w
6 Jan 20
Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
4:52pm
424B5
slbk9c3c5p7rhcxldj
6 Jan 20
Prospectus supplement for primary offering
4:42pm
S-3ASR
xpmsc3
6 Jan 20
Automatic shelf registration
4:02pm
8-K
EX-99.1
1yf5i
18 Dec 18
Intra-Cellular Therapies Announces Update onITI-007-201 Clinical Trial for Treatment of Agitation in Patients with Probable Alzheimer’s Disease
8:39am